Skip to product information
1 of 1

Elabscience

SKU:E-AB-F1083D-20Tests

PE Anti-Human CD33 Antibody[6C5]

PE Anti-Human CD33 Antibody[6C5]

Regular price $200.00 USD
Regular price Sale price $200.00 USD
Sale Sold out
Shipping calculated at checkout.
Size
The PE Anti-Human CD33 Antibody[6C5] is a highly reliable and efficient product designed for the specific detection and analysis of CD33 antigen expression in human samples. This antibody, conjugated with phycoerythrin (PE), offers exceptional sensitivity and specificity, making it an ideal tool for various research applications.

The CD33 antigen, a transmembrane glycoprotein, is predominantly expressed on myeloid cells, including monocytes, granulocytes, and dendritic cells. It plays a crucial role in regulating immune responses and is implicated in various hematological disorders, including acute myeloid leukemia (AML). The PE Anti-Human CD33 Antibody[6C5] enables researchers to accurately identify and quantify CD33 expression levels, facilitating a deeper understanding of its involvement in disease pathogenesis.

This antibody is manufactured using advanced techniques, ensuring high purity and consistency in every batch. Its exceptional binding affinity and minimal background noise guarantee reliable and reproducible results. The PE conjugation enhances the signal intensity, enabling easy detection and analysis by flow cytometry or other fluorescence-based techniques.

The PE Anti-Human CD33 Antibody[6C5] is supplied in a convenient format, allowing for immediate use in various experimental settings. It is provided in a liquid formulation, eliminating the need for reconstitution, and is compatible with most common sample types, including peripheral blood, bone marrow, and cell lines.

With its exceptional performance and ease of use, the PE Anti-Human CD33 Antibody[6C5] is an indispensable tool for researchers and clinicians involved in the study of hematological disorders and immune responses. Its reliable and accurate results contribute to advancing our understanding of CD33 biology and its potential as a therapeutic target.
View full details